The MicroRNA-148/152 Family: Multi-faceted Players

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Chen, Yue ^a,b   Song, Yong Xi ^a   Wang, Zhen Ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Cancer Hospital and Institute   (China)

Author keywords

Disease; MiR 148 152 family; Normal tissue

Indexed keywords

DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 148A; MICRORNA 148B; MICRORNA 152; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; BILE DUCT CARCINOMA; BIOGENESIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; COLORECTAL CANCER; CPG ISLAND; DIGESTIVE SYSTEM CANCER; EMBRYONIC STEM CELL; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE SILENCING; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER INJURY; MESENCHYMAL STEM CELL; METASTASIS; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PROSTATE CANCER; RADIOSENSITIVITY; RECEPTOR UPREGULATION; REVIEW; RNA STRUCTURE; STOMACH CANCER;

DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MULTIGENE FAMILY; NUCLEIC ACID CONFORMATION; ORGAN SPECIFICITY;

EID: 84877822045     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-43     Document Type: Review

References (77)

1. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060. 10.1038/sj.emboj.7600385, 524334, 15372072.
2. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016. 10.1101/gad.1158803, 305252, 14681208.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
4. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol 2003, 13:807-818. 10.1016/S0960-9822(03)00287-2, 12747828.
5. Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, Liu L, Jia D, Tian Q, Wu J, Ye Y, Wang Q, Long Z, Zhou Y, Du C, He X, Shi Y. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 2011, 17:7574-7583. 10.1158/1078-0432.CCR-11-1714, 21994419.
6. Wu XJ, Li Y, Liu D, Zhao LD, Bai B, Xue MH. miR-27a as an Oncogenic microRNA of Hepatitis B Virus- related Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2013, 14:885-889.
7. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, Liu Z. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010, 14:1170-1179. 10.1007/s11605-010-1202-2, 20422307.
8. Merkerova M, Vasikova A, Belickova M, Bruchova H. MicroRNA expression profiles in umbilical cord blood cell lineages. Stem Cells Dev 2010, 19:17-26. 10.1089/scd.2009.0071, 19435428.
9. Giraud-Triboult K, Rochon-Beaucourt C, Nissan X, Champon B, Aubert S, Pietu G. Combined mRNA and microRNA profiling reveals that miR-148a and miR-20b control human mesenchymal stem cell phenotype via EPAS1. Physiol Genomics 2011, 43:77-86. 10.1152/physiolgenomics.00077.2010, 21081659.
10. Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y, Fan Q, Ma B. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 2011, 112:1844-1856. 10.1002/jcb.23106, 21416501.
11. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force AS, Fedorov Y. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One 2009, 4:e5605. 10.1371/journal.pone.0005605, 2680014, 19440384.
12. Zhang J, Ying ZZ, Tang ZL, Long LQ, Li K. MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene. J Biol Chem 2012, 287:21093-21101. 10.1074/jbc.M111.330381, 22547064.
13. John E, Wienecke-Baldacchino A, Liivrand M, Heinaniemi M, Carlberg C, Sinkkonen L. Dataset integration identifies transcriptional regulation of microRNA genes by PPARgamma in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res 2012, 40:4446-4460. 10.1093/nar/gks025, 3378868, 22319216.
14. Farid WR, Pan Q, der Meer AJ, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HL, Metselaar HJ, Tilanus HW, Kazemier G, der Laan LJ. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012, 18:290-297. 10.1002/lt.22438, 21932376.
15. Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li N, Cao X. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol 2010, 185:7244-7251. 10.4049/jimmunol.1001573, 21068402.
16. Manaster I, Goldman-Wohl D, Greenfield C, Nachmani D, Tsukerman P, Hamani Y, Yagel S, Mandelboim O. MiRNA-mediated control of HLA-G expression and function. PLoS One 2012, 7:e33395. 10.1371/journal.pone.0033395, 3306401, 22438923.
17. Palmieri A, Pezzetti F, Brunelli G, Martinelli M, Scapoli L, Arlotti M, Masiero E, Carinci F. Medpor regulates osteoblast's microRNAs. Biomed Mater Eng 2008, 18:91-97.
18. Wang LL, Zhang Z, Li Q, Yang R, Pei X, Xu Y, Wang J, Zhou SF, Li Y. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 2009, 24:562-579.
19. Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying Y, Mao P. MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis. J Radiat Res 2012, 53:516-525. 10.1093/jrr/rrs002, 22843616.
20. Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D. MicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys 2011, 81:839-848. 10.1016/j.ijrobp.2010.09.048, 3056910, 21093163.
21. Huang JJ, Yu J, Li JY, Liu YT, Zhong RQ. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Med Oncol 2012, 29:2402-2408. 10.1007/s12032-012-0210-3, 22447484.
22. Serino G, Sallustio F, Cox SN, Pesce F, Schena FP. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol 2012, 23:814-824. 10.1681/ASN.2011060567, 3338289, 22362909.
23. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012, 2012:896362. 3398606, 22829805.
24. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, Koeppel TA, Zernecke A, Weber C. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012, 107:619-625. 10.1160/TH11-09-0607, 22370758.
25. Brenu EW, Ashton KJ, van DM, Staines DR, Peterson D, Atkinson GM, Marshall-Gradisnik SM. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Affect Disord 2012, 141:261-269. 10.1016/j.jad.2012.03.037, 22572093.
26. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, Junkermann H, Schneeweiss A, Burwinkel B. Circulating microRNAs in plasma as early detection markers for breast cancer. LID. Int J Cancer 2012,
27. Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012, 7:e35331. 10.1371/journal.pone.0035331, 3322146, 22496917.
28. Gokhale A, Kunder R, Goel A, Sarin R, Moiyadi A, Shenoy A, Mamidipally C, Noronha S, Kannan S, Shirsat NV. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther 2010, 6:521-529. 10.4103/0973-1482.77072, 21358093.
29. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010, 7:77-86. 10.1038/nrcardio.2009.228, 2813241, 20065951.
30. Li R, Qian N, Tao K, You N, Wang X, Dou K. MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res 2010, 29:169. 10.1186/1756-9966-29-169, 3022676, 21176238.
31. Zhao Y, Jia HL, Zhou HJ, Dong QZ, Fu LY, Yan ZW, Sun J, Ren N, Ye QH, Qin LX. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR]. Zhonghua Gan Zang Bing Za Zhi 2009, 17:526-530.
32. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010, 52:60-70. 10.1002/hep.23660, 20578129.
33. Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T, Devito R, Di MA, Antoccia A, Lorenzetti S, Maranghi F, Mantovani A, Tanzarella C, Macino G, Taruscio D. Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2009, 2:157-163. 2730135, 19701500.
34. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM, Zhang X, Jiang L, Xing CZ, Zhang Y. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011, 10:1. 10.1186/1476-4598-10-1, 3024301, 21205300.
35. Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao P, Xing C, Xu H. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 2012, 131:1042-1051. 10.1002/ijc.26485, 22020560.
36. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010, 51:881-890.
37. Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA, Tannapfel A. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 2011, 91:1472-1479. 10.1038/labinvest.2011.99, 21709669.
38. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, Wen YM, Wang CM, Yi XZ. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009, 28:64. 10.1186/1756-9966-28-64, 2687417, 19435529.
39. Zhou X, Zhao F, Wang ZN, Song YX, Chang H, Chiang Y, Xu HM. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep 2012, 27:447-454.
40. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010, 101:241-249. 10.1111/j.1349-7006.2009.01385.x, 19891660.
41. Fujita Y, Kojima K, Ohhashi R, Hamada N, Nozawa Y, Kitamoto A, Sato A, Kondo S, Kojima T, Deguchi T, Ito M. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 2010, 285:19076-19084. 10.1074/jbc.M109.079525, 2885186, 20406806.
42. Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J. Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. LID. Oncogene 2012,
43. Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L, Huang H, Han Z. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol 2012, 29:2701-2709. 10.1007/s12032-011-0134-3, 22167392.
44. Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010, 56:1107-1118. 10.1373/clinchem.2010.144709, 20431052.
45. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008, 105:13556-13561. 10.1073/pnas.0803055105, 2528872, 18768788.
46. Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes RX, Marquez VE, Pieters R, den Boer ML, Stam RW. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 2011, 25:429-439. 10.1038/leu.2010.282, 21116279.
47. Pavicic W, Perkio E, Kaur S, Peltomaki P. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach. Mol Med 2011, 17:726-735. 3146601, 21327300.
48. Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol 2013, 5:3-13. 10.1093/jmcb/mjs049, 3570052, 22935141.
49. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13:39-53.
50. Murata T, Takayama K, Katayama S, Urano T, Horie-Inoue K, Ikeda K, Takahashi S, Kawazu C, Hasegawa A, Ouchi Y, Homma Y, Hayashizaki Y, Inoue S. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis 2010, 13:356-361. 10.1038/pcan.2010.32, 20820187.
51. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.
52. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da PI, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
53. Griffiths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144. 10.1093/nar/gkj112, 1347474, 16381832.
54. Takagi S, Nakajima M, Mohri T, Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 2008, 283:9674-9680. 10.1074/jbc.M709382200, 18268015.
55. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y, Shen N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010, 184:6773-6781. 10.4049/jimmunol.0904060, 20483747.
56. Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H, Lai M. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 2011, 18:1702-1710. 10.1038/cdd.2011.28, 3190106, 21455217.
57. Guo SL, Peng Z, Yang X, Fan KJ, Ye H, Li ZH, Wang Y, Xu XL, Li J, Wang YL, Teng Y, Yang X. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci 2011, 7:567-574. 3088878, 21552422.
58. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, Pereyra F, Goldstein D, Wolinsky S, Walker B, Young HA, Carrington M. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498. 10.1038/nature09914, 3084326, 21499264.
59. Song H, Wang Q, Wen J, Liu S, Gao X, Cheng J, Zhang D. ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans Progressiva, Is Negatively Regulated by miR-148a. Int J Mol Sci 2012, 13:2063-2077. 10.3390/ijms13022063, 3292007, 22408438.
60. Zhu XM, Han T, Wang XH, Li YH, Yang HG, Luo YN, Yin GW, Yao YQ. Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am J Obstet Gynecol 2010, 202:592. e1-7.
61. Woo HH, Laszlo CF, Greco S, Chambers SK. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152. Mol Cancer 2012, 11:58. 10.1186/1476-4598-11-58, 22909061.
62. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res 2011, 71:6450-6462. 10.1158/0008-5472.CAN-11-0364, 21868754.
63. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054. 10.1056/NEJMra023075, 14627790.
64. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27:2291-2298. 10.1093/nar/27.11.2291, 148793, 10325416.
65. Tennis MA, Vanscoyk MM, Wilson LA, Kelley N, Winn RA. Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer. PLoS One 2012, 7:e32921. 10.1371/journal.pone.0032921, 3293913, 22403725.
66. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378. 10.1074/jbc.273.22.13375, 9593664.
67. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997, 57:4736-4738.
68. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997, 57:4183-4186.
69. Kubo Y, Urano Y, Hida Y, Arase S. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin. J Dermatol Sci 1999, 19:199-201. 10.1016/S0923-1811(98)00058-9, 10215192.
70. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997, 57:4997-5000.
71. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658. 10.1053/j.gastro.2007.05.022, 17681183.
72. Bar N, Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010, 5:e10859. 10.1371/journal.pone.0010859, 2877705, 20523723.
73. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le SC, Agami R, Tuschl T, Holland EC. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009, 23:1327-1337. 10.1101/gad.1777409, 2701585, 19487573.
74. Pagliocca A, Wroblewski LE, Ashcroft FJ, Noble PJ, Dockray GJ, Varro A. Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. Am J Physiol Gastrointest Liver Physiol 2002, 283:G292-G299.
75. Xie B, He SW, Wang XD. Effect of gastrin on protein kinase C and its subtype in human colon cancer cell line SW480. World J Gastroenterol 2000, 6:304-306.
76. Yen TW, Sandgren EP, Liggitt HD, Palmiter RD, Zhou W, Hinds TR, Grippo PJ, McDonald JM, Robinson LM, Bell RH. The gastrin receptor promotes pancreatic growth in transgenic mice. Pancreas 2002, 24:121-129. 10.1097/00006676-200203000-00002, 11854616.
77. Moody TW, Jensen RT. CI-988 inhibits growth of small cell lung cancer cells. J Pharmacol Exp Ther 2001, 299:1154-1160.